Technical Analysis for BNTC - Benitec Biopharma Limited

Grade Last Price % Change Price Change
C 5.14 0.78% 0.04
BNTC closed up 0.78 percent on Monday, March 18, 2024, on 14 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish 0.78%
Wide Bands Range Expansion 0.78%
Wide Bands Range Expansion -0.58%
Gapped Up Strength -0.58%
Calm After Storm Range Contraction -0.96%
Wide Bands Range Expansion -0.96%
Up 3 Days in a Row Strength -0.96%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 8 hours ago
10 DMA Support about 11 hours ago
60 Minute Opening Range Breakout about 11 hours ago
Up 1% about 11 hours ago
10 DMA Support 3 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Benitec Biopharma Limited Description

Benitec Biopharma Limited, a biotechnology company, develops novel treatments for chronic and life-threatening conditions based on its gene silencing technology, DNA-directed RNA interference (ddRNAi). The company's ddRNAi technology provides novel therapeutics to treat a range of human medical diseases and conditions, such as hepatitis C, hepatitis B, wet age-related macular degeneration, cancer-associated pain, drug resistant lung cancer, and oculopharyngeal muscular dystrophy (OPMD). Its pipeline of in-house and partnered therapeutic programs include TT-034 for hepatitis C; Tribetarna for the treatment of chemotherapy resistant non-small cell lung cancer; Hepbarna for Hepatitis B; and Pabparna for the treatment of OPMD. The company also licenses its ddRNAi technology to biopharmaceutical companies for the clinical applications comprising HIV/AIDS, retinitis pigmentosa, and Huntington's disease. Benitec Biopharma Limited was founded in 1997 and is based in Sydney, Australia.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Biopharmaceutical Biology Pain Genetics Chemotherapy Small Cell Lung Cancer Genetic Engineering Hepatitis B Macular Degeneration Gene Expression Dystrophy Muscular Dystrophy Hepatitis C Huntington's Disease Wet Age Related Macular Degeneration HIV/Aids RNA Clinical Applications Retinitis Rna Interference Ai Technology Gene Silencing Retinitis Pigmentosa Chronic And Life Threatening Conditions Oculopharyngeal Muscular Dystrophy

Is BNTC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.01
52 Week Low 1.86
Average Volume 15,812
200-Day Moving Average 3.42
50-Day Moving Average 3.64
20-Day Moving Average 4.66
10-Day Moving Average 5.09
Average True Range 0.34
RSI (14) 65.16
ADX 44.77
+DI 37.85
-DI 12.94
Chandelier Exit (Long, 3 ATRs) 4.93
Chandelier Exit (Short, 3 ATRs) 3.77
Upper Bollinger Bands 6.01
Lower Bollinger Band 3.32
Percent B (%b) 0.68
BandWidth 57.70
MACD Line 0.48
MACD Signal Line 0.49
MACD Histogram -0.0141
Fundamentals Value
Market Cap 13.22 Million
Num Shares 2.57 Million
EPS -234.82
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 98.27
Price-to-Book 0.33
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.29
Resistance 3 (R3) 5.28 5.23 5.26
Resistance 2 (R2) 5.23 5.19 5.23 5.26
Resistance 1 (R1) 5.19 5.17 5.21 5.19 5.25
Pivot Point 5.13 5.13 5.14 5.13 5.13
Support 1 (S1) 5.09 5.09 5.11 5.09 5.03
Support 2 (S2) 5.03 5.07 5.03 5.02
Support 3 (S3) 4.99 5.03 5.02
Support 4 (S4) 4.99